Closing of $5.5 Million Public Offering.
ANN ARBOR, MI / ACCESSWIRE / December 18, 2020 / ENDRA Life Sciences Inc. ("ENDRA") (NASDAQ:NDRA), a developer of enhanced ultrasound technologies, today reported the...
And Slowly But Surely..We Have Another 10-Bagger. PetVivo (PETV).
Things moving rather swimmingly at Pet-Vivo (PETV). Well, chart-wise.
REWARDS GO TO THE PATIENT?
Jim Kwik and Kevin Harrington Join Hapbee Technologies (HAPB) Board.
Hapbee Announces Additions to Advisory Board
December 17, 2020
New Advisors Bring Decades of Entrepreneurial ExperienceWellness...
Hapbee (HAPB): The Netflix of Feelings
After 15 years, $70 million spent on R&D, and 350,000+ hours of testing, this "Netflix of Feelings" wearable technology is finally...
Aphex BioCleanse Systems (SNST) Signs European Supply and Private Label Agreement for DermAphex® and...
PITTSFORD, N.Y. , Dec. 16, 2020 /PRNewswire/ -- Aphex BioCleanse Systems, Inc. (OTCPK: SNST) ("Aphex" or "the Company") , a sanitization solutions company focused on the development and distribution...
Mitesco (MITI) Expands ‘The Good Clinic’ to Colorado.
Mitesco Expands Footprint for The Good Clinic to Colorado at Lennar Multi-Family Developments to Serve as Stepping Stone to National Presence
Scott Donnell Used His Intuition to Launch Hapbee (HAPB). Video.
My next guest, Scott Donnell, who is a serial entrepreneur and CEO of Hapbee (www.hapbee.com), had a knack for business early in...
BioSig (BSGM) Achieves First Commercial Sale of Three PURE EP Systems
Sale Marks Milestone for Company's Commercial expansion at leading Center of Excellence
Westport,...
Some Scientists Aren’t So Sure A Coronavirus Vaccine Will Come To The Rescue.
Pandemic-weary residents everywhere are holding their breath for the first coronavirus vaccines to be approved by federal regulators. The shots, currently being...
Hepion Pharma Doses First Patient in the ‘AMBITION’ Clinical Trial.
Hepion Pharmaceuticals Completes 75 mg CRV431 Dosing, Initiates 225 mg Dosing in Phase 2a 'AMBITION' Clinical Trial for NASH.
Latest article
Ardelyx (ARDX) Reports First Quarter 2024 Showing $204 Million in Cash!
When we added Ardelyx (ARDX) to the Watch List in November of 2022, the market cap near $80 million. Now it's...
GeoVax to Provide Corporate Update on Tuesday May 14, 2024.
Still our favorite biotech microcap, still our favorite management team, and our favorite risk to reward idea with a $4 million market...
NovaVax (NVAX) Roars Higher, Gaining 225% a $1.2 Billion Increase, at the Blink of...
Sanofi (SNY) Announces Partnership - $500 Million Upfront, plus $700 million in Milestones with NovaVax (NVAX). And some investors say Covid is...
